The triple screening test consists of a blood test to determine biochemical markers (beta-hCG and PAPP-A) and an ultrasound to calculate the nuchal translucency measurement.
In addition, other clinical data of the pregnant woman are also taken into account, such as her weight, age, weeks of gestation, etc.
Read the full article on: Nuchal translucency and combined first trimester screening ( 57).
By Óscar Oviedo Moreno M.D. (gynecologist), Zaira Salvador B.Sc., M.Sc. (embryologist) and Cristina Algarra Goosman B.Sc., M.Sc. (psychologist).
Last Update: 02/11/2022
